FactEvidence 1
acquiresWarp Drive Bio
No public evidence summary is available.
钛媒体 · 2026-10-14 18:30
View evidence
- Media钛媒体2026-10-14 18:30View source
Company
RevMed
Structure of RevMed
RevMed
Company
2 connections
PeersCompetition and partners
OwnershipInvestment and holdings
Relationship began
RevMedCompany · 2 connections
Layer 1PeersCompetition and partners1
OwnershipInvestment and holdings1
Place in the network
No. 7989 of 43607top 19%
2 direct links
In a group of 322 closely linked entities, around
Weighted by public relations with evidence, recomputed daily.
Relations
Money between companies
Who invests in, owns, acquires or finances whom, from the relations AiSeek holds with evidence.
From RevMed
- Warp Drive Bioacquires
Lines show that a relation exists and which way it points; their thickness carries no amount. Dots only move to show the direction.
Arrows show the direction of the relationship. Filter to focus on a business area.
- Company · Warp Drive BioEvidence 1Fact55%
View evidence
- Media钛媒体2026-10-14 18:30View source
- Company · Royalty PharmaEvidence 1Fact55%
View evidence
- Media钛媒体2026-10-14 18:30View source
Showing 1 to 2 of 2
Claims
Read the assertion alongside its sources. Expand a row to inspect the evidence.
FactEvidence 1
preferred shares received by sanofi after the transaction约336.3万 股优先股
No public evidence summary is available.
钛媒体 · 2026-10-14 18:30
View evidence
- Media钛媒体2026-10-14 18:30View source
FactEvidence 1
ipo issue price17 美元
No public evidence summary is available.
钛媒体 · 2026-10-14 18:30
View evidence
- Media钛媒体2026-10-14 18:30View source
FactEvidence 1
ipo proceeds2.38 亿美元
No public evidence summary is available.
钛媒体 · 2026-10-14 18:30
View evidence
- Media钛媒体2026-10-14 18:30View source
FactEvidence 1
stock gain on first trading day66 %
No public evidence summary is available.
钛媒体 · 2026-10-14 18:30
View evidence
- Media钛媒体2026-10-14 18:30View source
FactEvidence 1
stock price change9.81 %
No public evidence summary is available.
钛媒体 · 2026-10-14 18:30
View evidence
- Media钛媒体2026-10-14 18:30View source
Showing 1 to 6 of 11
Market and valuation
Valuation data is available on Pro and Research.
Included in ProSuggest a page to watch
Know a page of this company that matters, such as pricing, a changelog, terms or careers? Suggest it. We read every suggestion; a page we add is watched for everyone, and we only count a change when two looks in a row agree.
Not available: Company signals · Financials · Filings · Sites · Guidance